FOXA2 and cancer: These in vitro results were in line with a recent study concluding that EMT of colon cancer can be suppressed by down‐regulating FOXA2 with a decrease in E‐cadherin and Vimentin.[26] Therefore, we assumed that the regulatory effects of FOXA2 on EMT and metastasis events are largely dependent on the different types of cancer cells, thus requiring more studies for specific tumor types.